<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
                      "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=US-ASCII">
<meta name="generator" content="hypermail 2.1.5, see http://www.hypermail.org/">
<title>Extropians: BIOLOGY: The Grand Challenges</title>
<meta name="Author" content="Robert J. Bradbury (bradbury@aeiveos.com)">
<meta name="Subject" content="BIOLOGY: The Grand Challenges">
<meta name="Date" content="2003-06-20">
<style type="text/css">
body {color: black; background: #ffffff}
h1.center {text-align: center}
div.center {text-align: center}
</style>
</head>
<body>
<h1>BIOLOGY: The Grand Challenges</h1>
<!-- received="Fri Jun 20 19:27:58 2003" -->
<!-- isoreceived="20030621012758" -->
<!-- sent="Fri, 20 Jun 2003 18:27:55 -0700 (PDT)" -->
<!-- isosent="20030621012755" -->
<!-- name="Robert J. Bradbury" -->
<!-- email="bradbury@aeiveos.com" -->
<!-- subject="BIOLOGY: The Grand Challenges" -->
<!-- id="Pine.LNX.4.44.0306201814420.14895-100000@server.aeiveos.com" -->
<!-- charset="US-ASCII" -->
<!-- expires="-1" -->
<p>
<strong>From:</strong> Robert J. Bradbury (<a href="mailto:bradbury@aeiveos.com?Subject=Re:%20BIOLOGY:%20The%20Grand%20Challenges"><em>bradbury@aeiveos.com</em></a>)<br>
<strong>Date:</strong> Fri Jun 20 2003 - 19:27:55 MDT
</p>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="10691.html">Damien Broderick: "lost linguistic battles (was: Re: developing countries)"</a>
<ul>
<li><strong>Previous message:</strong> <a href="10689.html">Robert J. Bradbury: "Re: Harvard, MIT Team Up to Explore Genomic Frontier"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#10690">[ date ]</a>
<a href="index.html#10690">[ thread ]</a>
<a href="subject.html#10690">[ subject ]</a>
<a href="author.html#10690">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<hr>
<!-- body="start" -->
<p>
Some may not know it, but the Human Genome was &quot;officially&quot;
<br>
declared complete in April.  At that time Francis Collins,
<br>
the director of NHGRI (<a href="http://www.genome.gov">http://www.genome.gov</a>), and several
<br>
other authors published a paper in Nature [1] discussing
<br>
the status of the work and future goals.  In that paper
<br>
they outlines a list of 5 future goals.
<br>
<p>I thought it might be useful for people to know what the
<br>
goals are:
<br>
<p>1. the ability to determine a genotype at very low cost,
<br>
&nbsp;&nbsp;&nbsp;allowing an association study in which 2,000 individuals
<br>
&nbsp;&nbsp;&nbsp;could be screened with about 400,000 genetic markers for
<br>
&nbsp;&nbsp;&nbsp;$10,000 or less;
<br>
2. the ability to sequence DNA at costs that are lower by
<br>
&nbsp;&nbsp;&nbsp;four to five *orders of magnitude* than the current cost,
<br>
&nbsp;&nbsp;&nbsp;allowing a human genome to be sequenced for $1,000 or less;
<br>
3. the ability to synthesize long DNA molecules at high
<br>
&nbsp;&nbsp;&nbsp;accuracy for $0.01 per base allowing the synthesis of
<br>
&nbsp;&nbsp;&nbsp;gene-sized pieces of DNA of any sequence for between $10
<br>
&nbsp;&nbsp;&nbsp;and $10000;
<br>
4. the ability to determine the methylation status of all
<br>
&nbsp;&nbsp;&nbsp;the DNA in a single cell; and
<br>
5. the ability to monitor the state of all proteins in a
<br>
&nbsp;&nbsp;&nbsp;single cell in a single experiment.
<br>
<p>#1 is very useful for identifying the genes involved in
<br>
various genetic diseases.  #2 is useful for determining
<br>
what actual gene defects an individual has as well as
<br>
contributing to knowing how they might respond to specific
<br>
therapies.  #3 is highly useful for developing gene based
<br>
therapies and reducing the costs of research.  [Interestingly,
<br>
the Robiobotics business plan goes far beyond goal #3.]
<br>
#4 may have some interesting consequences in understanding
<br>
aspects of aging.  #5 helps contribute to both basic
<br>
biological understanding as well as determining more
<br>
rapidly whether therapies are functioning as desired.
<br>
<p>Robert
<br>
<p>1. Collins, F. S., et al, &quot;A vision for the future of
<br>
genomics research&quot;, Nature 422:835-847 (24 Apr 2003).
<br>
<!-- body="end" -->
<hr>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="10691.html">Damien Broderick: "lost linguistic battles (was: Re: developing countries)"</a>
<li><strong>Previous message:</strong> <a href="10689.html">Robert J. Bradbury: "Re: Harvard, MIT Team Up to Explore Genomic Frontier"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#10690">[ date ]</a>
<a href="index.html#10690">[ thread ]</a>
<a href="subject.html#10690">[ subject ]</a>
<a href="author.html#10690">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<!-- trailer="footer" -->
<hr>
<p><small><em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2.1.5</a> 
: Fri Jun 20 2003 - 19:37:37 MDT
</em></small></p>
</body>
</html>
